TW200612941A - Quinorone-containing pharmaceutical composition - Google Patents

Quinorone-containing pharmaceutical composition

Info

Publication number
TW200612941A
TW200612941A TW094122435A TW94122435A TW200612941A TW 200612941 A TW200612941 A TW 200612941A TW 094122435 A TW094122435 A TW 094122435A TW 94122435 A TW94122435 A TW 94122435A TW 200612941 A TW200612941 A TW 200612941A
Authority
TW
Taiwan
Prior art keywords
compound
component
quinorone
pharmaceutical composition
containing pharmaceutical
Prior art date
Application number
TW094122435A
Other languages
English (en)
Inventor
Emi Yano
Hideo Kobayashi
Hiroshi Kikuchi
Yuri Yamaguchi
Toshimasa Jindo
Norihiro Nishimoto
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of TW200612941A publication Critical patent/TW200612941A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
TW094122435A 2004-07-02 2005-07-01 Quinorone-containing pharmaceutical composition TW200612941A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004197223 2004-07-02

Publications (1)

Publication Number Publication Date
TW200612941A true TW200612941A (en) 2006-05-01

Family

ID=35782832

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094122435A TW200612941A (en) 2004-07-02 2005-07-01 Quinorone-containing pharmaceutical composition

Country Status (14)

Country Link
US (1) US20090117205A1 (zh)
EP (1) EP1764102A4 (zh)
JP (1) JPWO2006004028A1 (zh)
KR (1) KR20070029280A (zh)
CN (1) CN1980670A (zh)
AU (1) AU2005258398A1 (zh)
CA (1) CA2572167A1 (zh)
IL (1) IL180316A0 (zh)
MX (1) MX2007000336A (zh)
NO (1) NO20070617L (zh)
RU (1) RU2007104026A (zh)
TW (1) TW200612941A (zh)
WO (1) WO2006004028A1 (zh)
ZA (1) ZA200700844B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2990039A4 (en) 2013-04-25 2017-02-22 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
US9603804B2 (en) 2013-04-25 2017-03-28 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
CA2965473A1 (en) 2014-10-23 2016-04-28 Kyorin-Pharmaceutical Co., Ltd. Solid pharmaceutical composition
WO2016195014A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
EP3305295A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
CA2988092A1 (en) * 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US111851A (en) * 1871-02-14 Improvement in treating bones, horns, hoofs
US100436A (en) * 1870-03-01 Improvement in the manufacture of combined cloth and paper fabric
DK0507851T3 (da) * 1989-12-29 1997-08-25 Abbott Lab Quinoloncarboxylsyre-matalion-syrekomplekser
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5602254A (en) * 1995-05-26 1997-02-11 Warner-Lambert Company Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form
ATE212551T1 (de) * 1995-12-21 2002-02-15 Pfizer Injizierbare quinolonformulierungen
PL339408A1 (en) * 1997-09-15 2000-12-18 Procter & Gamble Antimicrobial quinolones, agents containing them and their applications
ID21415A (id) * 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
CA2429440C (en) * 2000-11-20 2009-12-29 Daiichi Pharmaceutical Co., Ltd. Dehalogeno-compounds

Also Published As

Publication number Publication date
MX2007000336A (es) 2007-03-28
CA2572167A1 (en) 2006-01-12
WO2006004028A1 (ja) 2006-01-12
CN1980670A (zh) 2007-06-13
NO20070617L (no) 2007-03-30
ZA200700844B (en) 2009-07-29
EP1764102A4 (en) 2010-08-25
US20090117205A1 (en) 2009-05-07
AU2005258398A1 (en) 2006-01-12
EP1764102A1 (en) 2007-03-21
KR20070029280A (ko) 2007-03-13
IL180316A0 (en) 2007-07-04
RU2007104026A (ru) 2008-08-10
JPWO2006004028A1 (ja) 2008-04-24

Similar Documents

Publication Publication Date Title
TW200728307A (en) Novel spirochromanone derivatives
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2004096134A3 (en) Substituted 1,4-diazepines and uses thereof
CA2510853A1 (en) Pyrrolopyrimidine derivatives
UA94455C2 (en) Oxadiazolidinedione compound
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
WO2005046589A3 (en) Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
MY139704A (en) Naphthalene derivatives for use as histamine-3-receptor ligands
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200612941A (en) Quinorone-containing pharmaceutical composition
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
TW200716547A (en) Piperidin-4-yl-amide derivatives
WO2005005389A3 (en) Malonamide derivatives
WO2003049690A3 (en) Hiv integrase inhibitors
HK1076816A1 (zh)
WO2009020137A1 (ja) アミノピラゾールアミド誘導体
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2006036007A3 (en) Modified-release preparation
GB0212410D0 (en) Organic compounds
WO2008063548A3 (en) 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents